BillionToOne (BLLN) Total Non-Current Liabilities (2024 - 2025)
BillionToOne (BLLN) posted Total Non-Current Liabilities of $152.5 million for Q4 2025, up 6.47% sequentially from $143.3 million in Q3 2025, and up 15.97% YoY from $131.5 million in Q4 2024.
BillionToOne (BLLN) Total Non-Current Liabilities (2024 - 2025) Analysis & Trends
BillionToOne has reported Total Non-Current Liabilities for 2 years, with the latest figure at $152.5 million in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 15.97% year-over-year to $152.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $152.5 million (up 15.97% YoY) and the FY2025 annual result came in at $152.5 million, up 15.97% from the prior year.
- Total Non-Current Liabilities rose to $152.5 million in Q4 2025 per BLLN's latest filing, from $143.3 million in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $152.5 million in Q4 2025 and troughed at $131.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 542.10 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.88 Bn |
| 10 | BillionToOne | 6.88 Bn | 6.34 Bn | 79.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152.55 Mn |
| Sep 30, 2025 | 143.28 Mn |
| Dec 31, 2024 | 131.54 Mn |